Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Continuous-process-for-ethanol-production-by-bacterial-fermentation

 Systemic drug delivery compositions comprising a polycationi substance
I claim: 1. A method of systemically delivering a pharmaceutically effective amount of a ...


 Nucleic acid-containing composition, its preparation and use
We claim: 1. A composition comprising a deoxyribonucleic acid and a cationic oligopeptide that ...


 Peptide-enhanced cationic lipid transfections
OF THE INVENTION The present invention provides improved methods for transfecting eukaryotic cells ...


 Controlled release formulations coated with aqueous dispersions of acrylic polymers
It is therefore an object of the present invention to provide a controlled release formulation of a ...


 Xylofuranosly-containing nucleoside phosphoramidites and polynucleotides
What is claimed is: 1. A compound having the formula I: ##STR5## wherein, R.sub.1 is OH, O--R.sub.3,...


 Substituted indazole-O-glucosides
OF THE INVENTION All diabetics, regardless of their genetic and environmental backgrounds, have in ...


 Production in Escherichia coli of extracellular Serratia spp. hydrolases
We claim: 1. A method of producing an extracellular hydrolytic Serratia spp. enzyme selected from ...


 Modular assembly of antibody genes, antibodies prepared thereby and use
What is claimed is: 1. A polynucleotide molecule encoding an immunoglobulin fragment, said ...


 Cytoplasmic bacteriophage display system
The present invention relates, in one aspect, to a display vector comprising DNA encoding a portion ...


 Diagnosis of alzheimer disease stage by mononuclear cell cytokine secretions
AND ADVANTAGES According to the present invention, a method of diagnosing and determining the ...


 Continuous process for ethanol production by bacterial fermentation

Details
Inventors: Lawford, Hugh G.;
Assignee: George Weston Limited (Toronto, CA)
Primary Examiner: Warren; Charles F.
Assistant Examiner: Marx; Irene
Attorney, Agent or Firm: Finnegan, Henderson, Farabow, Garrett & Dunner

A continuous process for the production of ethanol by fermentation with strains of Zymomonas is provided. Metabolic processes are limited by the nutrients nitrogen, potassium and phosphorus. When growth is limited by one of these nutrients, the biomass expresses its maximum value for both q.sub.s and q.sub.p at any given value of D and S.sub.r. The process is conducted at a lower biomass concentration and a higher specific rate of ethanol formation than a similar process conducted with a nutrient medium that is not limited in nitrogen, potassium or phosphorus. A method of improving performance of Zymomonas in continuous ethanol fermentation at increased temperatures is also provided.

DETAILED DESCRIPTION The accompanying FIGURE will provide a background for the following discussion in which the method and apparatus for carrying out this invention are described in detail.
Referring to the FIGURE, nutrient medium 1 in reservoir 2 is fed by a pump 3 to a fermenter 4 containing a fermentation medium 5.
The medium is maintained at a constant volume in the fermenter by means of an overflow weir 6 that empties into a container 7.
Carbon dioxide formed during the fermentation is vented at 8.
The fermenter 4 is provided with an agitator 9 for mixing the fermenter contents.
A pH probe 10 is immersed in the fermentation medium 5 and is connected to a pH controller 11 for regulating the amount of pH regulating agent 12 in reservoir 13 added by a pump 14 to the fermentation medium 5.
The temperature of the fermentation medium is monitored by temperature probe 15.
The fermentation medium is heated or cooled as required through a coil 16 and regulated by the temperature controller 17.
The fermentation medium is formulated so that all but a single essential nutrient are available in excess of the amount required to synthesize a desired cell concentration.
The single growth-limiting nutrient controls the size of the steady-state cell population.
Conventional expressions are used throughout this description when the kinetics of the fermentation process are discussed.
The abbreviations identified in the following list have been used in order to facilitate the discussion.
Units of measure have been included where appropriate.
S.
sub.
r =Substrate concentration in the feed stream to the fermenter; g/liter, i.
e.
g/L.
S.
sub.
o =Substrate concentration in the effluent from the fermenter; g/L.
V=Volume of fermentation medium in the fermenter; L.
X=Concentration of biomass in the fermentation medium (dry basis); g/L.
[P]=Concentration of ethanol in the fermentation medium; g/L.
u=Specific growth rate (mass); hr.
sup.
-1.
D=Dilution rate; hr.
sup.
-1.
N*=Amount of a given nutrient; g.
q.
sub.
s =Specific rate of substrate uptake; g substrate/g biomass-hr



Related patents
  Stable solution of hyaluronate in a balanced salt medium
What is claimed is: 1. A physiological visco-elastic formulation consisting of sodium hyaluronate in an amount in the range of about 0.1% to about 5% by weight in a ...
  Radiolabeled fusion toxins for cancer therapy
The present invention describes the synthesis and purification of a new class of compounds known as radiolabeled fusion toxins (RFT), in which both toxin and ...
  Genetically modified cells expressing a TGF.beta. inhibitor, the cells being lung cancer cells
OF THE PREFERRED EMBODIMENT Lung cancers account for 30% of all death due to cancer in the United States (Ramanathan and Belani, 1997). The overall cure rate for lung ...
  Auto-ligating oligonucleotide compounds
OF THE INVENTION The invention relates to a method and compositions for in situ formation of an effective antisense compound or probe on a target polynucleotide. C...
  Nucleic acids encoding transcription factor APRF (acute phase response factor)
What is claimed: 1. An isolated DNA molecule which encodes a human APRF polypeptide having the amino acid sequence of SEQ ID No:1. 2. An isolated DNA molecule comprising ...
  Antisense modulation of stat3 expression
OF THE INVENTION STAT3 plays an important role in cytokine signal transduction. Overexpression and/or constitutive activation of STAT3 is associated with a number of ...
  Cold-active beta-galactosidase, the process for its preparation and the use thereof
The object of the present invention is to hydrolyse lactose by using a .beta.-galactosidase, which could overcome the above-mentioned drawbacks which are usually ...
  Method of delivering powder transdermally with needless injector
What we claim is: 1. A method of therapeutic treatment, comprising transdermally delivering particles of a powdered therapeutic agent across skin tissue of a mammalian ...
  Telomere repeat binding factors and diagnostic and therapeutic use thereof
The present invention provides vertebrate telomeric binding factors (TRFs) that bind to the TTAGGG repeat sequences of telomeres. Such TRFs comprise two key domains: a ...
  Protease-activated receptor PAR4 (ZCHEMR2)
What is claimed is: 1. An isolated polynucleotide molecule that encodes a polypeptide comprising amino acid residues 48 to 78 of SEQ ID NO:2. 2. The isolated ...

0.124

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved